Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

The interaction of lipid-liganded gold clusters (Aurora ) with lipid bilayers.

Sot J, Mendanha-Neto SA, Busto JV, García-Arribas AB, Li S, Burgess SW, Shaw WA, Gil-Carton D, Goñi FM, Alonso A.

Chem Phys Lipids. 2018 Nov 28;218:40-46. doi: 10.1016/j.chemphyslip.2018.11.007. [Epub ahead of print]

PMID:
30502315
2.

Clearly Detectable, Kinetically Restricted Solid-Solid Phase Transition in cis-Ceramide Monolayers.

Fanani ML, Busto JV, Sot J, Abad JL, Fabrías G, Saiz L, Vilar JMG, Goñi FM, Maggio B, Alonso A.

Langmuir. 2018 Oct 2;34(39):11749-11758. doi: 10.1021/acs.langmuir.8b02198. Epub 2018 Sep 24.

PMID:
30183303
3.

Lateral plasma membrane compartmentalization links protein function and turnover.

Busto JV, Elting A, Haase D, Spira F, Kuhlman J, Schäfer-Herte M, Wedlich-Söldner R.

EMBO J. 2018 Aug 15;37(16). pii: e99473. doi: 10.15252/embj.201899473. Epub 2018 Jul 5.

PMID:
29976762
4.

Pb(II) Induces Scramblase Activation and Ceramide-Domain Generation in Red Blood Cells.

Ahyayauch H, García-Arribas AB, Sot J, González-Ramírez EJ, Busto JV, Monasterio BG, Jiménez-Rojo N, Contreras FX, Rendón-Ramírez A, Martin C, Alonso A, Goñi FM.

Sci Rep. 2018 May 10;8(1):7456. doi: 10.1038/s41598-018-25905-8.

5.

Lipid-modified oligonucleotide conjugates: Insights into gene silencing, interaction with model membranes and cellular uptake mechanisms.

Ugarte-Uribe B, Grijalvo S, Pertíñez SN, Busto JV, Martín C, Alagia A, Goñi FM, Eritja R, Alkorta I.

Bioorg Med Chem. 2017 Jan 1;25(1):175-186. doi: 10.1016/j.bmc.2016.10.024. Epub 2016 Oct 20.

PMID:
27810441
6.

Cholesterol-Ceramide Interactions in Phospholipid and Sphingolipid Bilayers As Observed by Positron Annihilation Lifetime Spectroscopy and Molecular Dynamics Simulations.

García-Arribas AB, Axpe E, Mujika JI, Mérida D, Busto JV, Sot J, Alonso A, Lopez X, García JÁ, Ugalde JM, Plazaola F, Goñi FM.

Langmuir. 2016 May 31;32(21):5434-44. doi: 10.1021/acs.langmuir.6b00927. Epub 2016 May 18.

PMID:
27158737
7.

Atomic force microscopy characterization of palmitoylceramide and cholesterol effects on phospholipid bilayers: a topographic and nanomechanical study.

García-Arribas AB, Busto JV, Alonso A, Goñi FM.

Langmuir. 2015 Mar 17;31(10):3135-45. doi: 10.1021/la504047n. Epub 2015 Mar 4.

PMID:
25693914
8.

Low pH modulates the macroorganization and thermal stability of PSII supercomplexes in grana membranes.

Stoichev S, Krumova SB, Andreeva T, Busto JV, Todinova S, Balashev K, Busheva M, Goñi FM, Taneva SG.

Biophys J. 2015 Feb 17;108(4):844-853. doi: 10.1016/j.bpj.2014.12.042.

9.

Fluorescent polyene ceramide analogues as membrane probes.

Nieves I, Artetxe I, Abad JL, Alonso A, Busto JV, Fajarí L, Montes LR, Sot J, Delgado A, Goñi FM.

Langmuir. 2015 Mar 3;31(8):2484-92. doi: 10.1021/la505017x. Epub 2015 Feb 19.

PMID:
25658138
10.

Biophysical properties of novel 1-deoxy-(dihydro)ceramides occurring in mammalian cells.

Jiménez-Rojo N, Sot J, Busto JV, Shaw WA, Duan J, Merrill AH Jr, Alonso A, Goñi FM.

Biophys J. 2014 Dec 16;107(12):2850-2859. doi: 10.1016/j.bpj.2014.10.010.

11.

Solvation and hydration of the ceramide headgroup in a non-polar solution.

Gillams RJ, Busto JV, Busch S, Goñi FM, Lorenz CD, McLain SE.

J Phys Chem B. 2015 Jan 8;119(1):128-39. doi: 10.1021/jp5107789. Epub 2014 Dec 24.

PMID:
25496521
12.

N-nervonoylsphingomyelin (C24:1) prevents lateral heterogeneity in cholesterol-containing membranes.

Maté S, Busto JV, García-Arribas AB, Sot J, Vazquez R, Herlax V, Wolf C, Bakás L, Goñi FM.

Biophys J. 2014 Jun 17;106(12):2606-16. doi: 10.1016/j.bpj.2014.04.054.

13.

Lamellar gel (lβ) phases of ternary lipid composition containing ceramide and cholesterol.

Busto JV, García-Arribas AB, Sot J, Torrecillas A, Gómez-Fernández JC, Goñi FM, Alonso A.

Biophys J. 2014 Feb 4;106(3):621-30. doi: 10.1016/j.bpj.2013.12.021.

14.

Membrane binding and insertion of the predicted transmembrane domain of human scramblase 1.

Posada IM, Busto JV, Goñi FM, Alonso A.

Biochim Biophys Acta. 2014 Jan;1838(1 Pt B):388-97. doi: 10.1016/j.bbamem.2013.09.018. Epub 2013 Oct 4.

15.

Double-tailed lipid modification as a promising candidate for oligonucleotide delivery in mammalian cells.

Ugarte-Uribe B, Grijalvo S, Busto JV, Martín C, Eritja R, Goñi FM, Alkorta I.

Biochim Biophys Acta. 2013 Oct;1830(10):4872-84. doi: 10.1016/j.bbagen.2013.06.013. Epub 2013 Jun 23.

PMID:
23800579
16.

Insights into sphingolipid miscibility: separate observation of sphingomyelin and ceramide N-acyl chain melting.

Leung SS, Busto JV, Keyvanloo A, Goñi FM, Thewalt J.

Biophys J. 2012 Dec 19;103(12):2465-74. doi: 10.1016/j.bpj.2012.10.041. Epub 2012 Dec 18.

17.

Binding of β-amyloid (1-42) peptide to negatively charged phospholipid membranes in the liquid-ordered state: modeling and experimental studies.

Ahyayauch H, Raab M, Busto JV, Andraka N, Arrondo JL, Masserini M, Tvaroska I, Goñi FM.

Biophys J. 2012 Aug 8;103(3):453-63. doi: 10.1016/j.bpj.2012.06.043.

18.

Accumulated bending energy elicits neutral sphingomyelinase activity in human red blood cells.

López DJ, Egido-Gabas M, López-Montero I, Busto JV, Casas J, Garnier M, Monroy F, Larijani B, Goñi FM, Alonso A.

Biophys J. 2012 May 2;102(9):2077-85. doi: 10.1016/j.bpj.2012.03.020.

19.

Cholesterol displaces palmitoylceramide from its tight packing with palmitoylsphingomyelin in the absence of a liquid-disordered phase.

Busto JV, Sot J, Requejo-Isidro J, Goñi FM, Alonso A.

Biophys J. 2010 Aug 9;99(4):1119-28. doi: 10.1016/j.bpj.2010.05.032.

20.

Coexistence of immiscible mixtures of palmitoylsphingomyelin and palmitoylceramide in monolayers and bilayers.

Busto JV, Fanani ML, De Tullio L, Sot J, Maggio B, Goñi FM, Alonso A.

Biophys J. 2009 Nov 18;97(10):2717-26. doi: 10.1016/j.bpj.2009.08.040.

21.

Sphingosine-1-phosphate as an amphipathic metabolite: its properties in aqueous and membrane environments.

García-Pacios M, Collado MI, Busto JV, Sot J, Alonso A, Arrondo JL, Goñi FM.

Biophys J. 2009 Sep 2;97(5):1398-407. doi: 10.1016/j.bpj.2009.07.001.

22.

Combination of the anti-tumour cell ether lipid edelfosine with sterols abolishes haemolytic side effects of the drug.

Busto JV, Del Canto-Jañez E, Goñi FM, Mollinedo F, Alonso A.

J Chem Biol. 2008 Nov;1(1-4):89-94. doi: 10.1007/s12154-008-0009-z. Epub 2008 Jul 22.

23.

Cholesterol displacement by ceramide in sphingomyelin-containing liquid-ordered domains, and generation of gel regions in giant lipidic vesicles.

Sot J, Ibarguren M, Busto JV, Montes LR, Goñi FM, Alonso A.

FEBS Lett. 2008 Sep 22;582(21-22):3230-6. doi: 10.1016/j.febslet.2008.08.016. Epub 2008 Aug 26.

24.

Surface-active properties of the antitumour ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (edelfosine).

Busto JV, Sot J, Goñi FM, Mollinedo F, Alonso A.

Biochim Biophys Acta. 2007 Jul;1768(7):1855-60. Epub 2007 May 5. Erratum in: Biochim Biophys Acta. 2008 Oct;1778(10):2459.

Supplemental Content

Loading ...
Support Center